carnosine has been researched along with Autism in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afarideh, M; Akhondzadeh, S; Ghajar, A; Hajizadeh-Zaker, R; Mesgarpour, B; Mohammadi, MR | 1 |
Kheirouri, S; Mehrazad-Saber, Z; Noorazar, SG | 1 |
Ghodsi, R; Kheirouri, S; Nosrati, R | 1 |
Aimonovitch, MC; Becker, M; Black, C; Buchanan, CP; Chez, MG; Komen, J; Schaefer, K | 1 |
4 trial(s) available for carnosine and Autism
Article | Year |
---|---|
l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Antipsychotic Agents; Autism Spectrum Disorder; Autistic Disorder; Carnosine; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Irritable Mood; Linear Models; Male; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome | 2018 |
Effects of l-Carnosine Supplementation on Sleep Disorders and Disease Severity in Autistic Children: A Randomized, Controlled Clinical Trial.
Topics: Adolescent; Antioxidants; Autistic Disorder; Carnosine; Child; Child, Preschool; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Neuroprotective Agents; Parasomnias; Placebos; Severity of Illness Index; Sleep; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2018 |
Carnosine supplementation does not affect serum concentrations of advanced glycation and precursors of lipoxidation end products in autism: a randomized controlled clinical trial.
Topics: Autistic Disorder; Carnosine; Child; Child, Preschool; Dietary Supplements; Double-Blind Method; Female; Glycation End Products, Advanced; Humans; Male; Oxidative Stress | 2019 |
Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders.
Topics: Autistic Disorder; Carnosine; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Neuroprotective Agents; Psychiatric Status Rating Scales; Treatment Outcome | 2002 |